GILD - GILEAD SCIENCES, INC.
125.67
0.480 0.382%
Share volume: 1,606,328
Last Updated: 12-24-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$125.19
0.48
0.00%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 02-23-2024 | 05-08-2024 | 08-08-2024 | 11-12-2024 | 02-28-2025 | 05-07-2025 | 08-07-2025 | 11-07-2025 | |
| Total revenue | 7.115 B | 6.686 B | 6.954 B | 7.545 B | 7.569 B | 6.667 B | 7.082 B | 7.769 B | |
| Cost of revenue | 2.090 B | 1.552 B | 1.544 B | 1.574 B | 1.581 B | 1.540 B | 1.501 B | 1.569 B | |
| Gross profit | 5.025 B | 5.134 B | 5.410 B | 5.971 B | 5.988 B | 5.127 B | 5.581 B | 6.200 B | |
| 2.17% | 5.38% | 10.37% | 0.28% | -14.38% | 8.86% | 11.09% | |||
| Operating expenses | 3.014 B | 7.026 B | 2.766 B | 3.333 B | 3.536 B | 2.890 B | 2.917 B | 2.873 B | |
| Selling general and admin | 1.607 B | 1.375 B | 1.377 B | 1.433 B | 1.906 B | 1.258 B | 1.365 B | 1.357 B | |
| Research and development | 1.407 B | 5.651 B | 1.389 B | 1.900 B | 1.630 B | 1.632 B | 1.552 B | 1.516 B | |
| Total expenses | 5.104 B | 9.456 B | 2.766 B | 5.083 B | 3.536 B | 2.890 B | 3.107 B | 2.873 B | |
| 85.27% | -70.75% | 83.77% | -30.43% | -18.27% | 7.51% | -7.53% | |||
| Operating income | 2.011 B | -4.322 B | 2.644 B | 888.000 M | 2.452 B | 2.237 B | 2.474 B | 3.327 B | |
| Ebit | 2.011 B | -4.231 B | 2.289 B | 1.194 B | 2.416 B | 1.909 B | 2.682 B | 3.896 B | |
| Pretax income | 1.654 B | -4.486 B | 2.053 B | 956.000 M | 2.167 B | 1.649 B | 2.429 B | 3.641 B | |
| -371.22% | -145.76% | -53.43% | 126.67% | -23.90% | 47.30% | 49.90% | |||
| Income tax | 236.000 M | -315.000 M | 438.000 M | -297.000 M | 385.000 M | 334.000 M | 468.000 M | 589.000 M | |
| Net income basic | 1.429 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | |||||||||
| Net income | 1.429 B | -4.170 B | 1.614 B | 1.253 B | 1.783 B | 1.315 B | 1.960 B | 3.052 B | |
| -391.81% | 138.71% | -22.37% | 42.30% | -26.25% | 49.05% | 55.71% |